This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Paion UK Limited. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Daisuke Tanaka: Innovator in Pharmaceutical Chemistry
Introduction
Daisuke Tanaka is a prominent inventor based in Fukui, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for synthesizing complex compounds. With a total of three patents to his name, Tanaka's work is recognized for its impact on drug development and production.
Latest Patents
Tanaka's latest patents include a process for preparing 3-[(S)-7-bromo-2-((2-oxopropyl)amino)-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]propionic acid methyl ester. This process achieves a high conversion rate with good reproducibility by oxidizing a precursor compound in the presence of an oxidation catalyst. Another notable patent involves the preparation of 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propionic acid methyl ester benzenesulfonate, also utilizing an oxidation catalyst for efficient synthesis.
Career Highlights
Daisuke Tanaka is currently employed at Paion UK Limited, where he continues to advance his research in pharmaceutical innovations. His expertise in chemical processes has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Tanaka has collaborated with notable colleagues, including Yuji Kawakami and Tatsushi Murase. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in their field.
Conclusion
Daisuke Tanaka's contributions to pharmaceutical chemistry through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in drug synthesis and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile